Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Hartung, T.
Автор Volk, H-D.
Автор Wendel, A.
Дата выпуска 1995
dc.description We have previously reported that in various macrophage populations prepared from G-CSF treated rats LPS-inducible TNF release was suppressed. In vitro, LPS induced liver cell death only when hepatocytes were cocultured with liver macrophages. Rat Kupffer cells from G-CSF treated donor animals were less potent in mediating LPS-inducible hepatocytotoxicity in vitro than cells from control animals. These ex vivo findings were confirmed in vivo by demonstrating that G-CSF treatment attenuated LPS-inducible circulating TNF levels and protected from liver injury and mortality.We extended these observations to humans in two studies with G-CSF treated volunteers. In a pilot study, 11 subjects were treated single-blindly with 480 μg G-CSF s.c. (n = 7) or saline placebo (n = 4). Blood was taken at different time-points relative to G-CSF injection and cytokine release capacity was assessed in LPS stimulated whole blood incubations. In blood from G-CSF treated volunteers, we found reduced LPS-inducible TNF formation while the release of both soluble TNF receptor (sTNF-R) and interleukin 1 receptor antagonist (IL-1ra) were increased. In a second double-blind, randomized and controlled study, three groups of seven volunteers were treated once or twice 24 h apart with G-CSF or solvent placebo. Besides LPS, various stimuli were included to initiate cytokine release in a whole blood assay. The reduction of TNF formation (mean 53 % at 24 h after G-CSF) was different with the various stimuli. All stimuli increased IL-1ra (mean 14-fold) and sTNF-R (mean 3-fold) at 24 h after G-CSF. LPS-inducible IFN-γ and GM-CSF were significantly reduced. Our data indicate that the pattern of cytokines produced by human whole blood taken after G-CSF treatment in response to a variety of stimuli is shifted from pro- to anti-inflammatory mediators. These findings extend the knowledge on the pharmacology of G-CSF in animal models of the systemic inflammatory response syndrome and prompt a trial of G-CSF prophylaxis with this indication.
Издатель Sage Publications
Название G-CSF - an anti-inflammatory cytokine
Тип Journal Article
DOI 10.1177/096805199500200308
Print ISSN 0968-0519
Журнал Journal of Endotoxin Research
Том 2
Первая страница 195
Последняя страница 201
Аффилиация Hartung, T., Department of Biochemical Pharmacology, University of Konstanz, Department of Clinical Immunology, Charité Berlin, Germany
Аффилиация Volk, H-D., Department of Biochemical Pharmacology, University of Konstanz, Department of Clinical Immunology, Charité Berlin, Germany
Аффилиация Wendel, A., Department of Biochemical Pharmacology, University of Konstanz, Department of Clinical Immunology, Charité Berlin, Germany
Выпуск 3
Библиографическая ссылка Matsumoto M. , Matsubara S., Matsuno T. et al. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun 1987; 55: 2715-2720.
Библиографическая ссылка O'Reilly M., Silver GM, Grenhalgh DG, Gamelli RL, Davis JH, Hebert CHTreatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma1992; 33: 679-682.
Библиографическая ссылка Cairo MS, Plunkett JM, Nguyen A., van de Ven C.Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis . Blood 1992; 80: 96-101.
Библиографическая ссылка Fink MP, O'Sullivan BP, Menconi MJ et al. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993; 34: 571-578.
Библиографическая ссылка Morstyn G., Lieschke GJ, Sheridan W., Layton J., Cebon J.Pharmacology of the colony-stimulating factors. Trends Pharmacol Sci1989; 10: 154-159.
Библиографическая ссылка Lang CH, Bagby GJ, Dobrescu C., Nelson S., Spitzer JJEffect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J Infect Dis1992; 166:336-343.
Библиографическая ссылка Yuo A., Kitagawa S., Ohsaka A., Saito M., Takaku F.Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences. Biochem Biophys Res Commun1990; 171: 491-497.
Библиографическая ссылка Balazovich KJ , Almeida HI, Boxer LA Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms. J Lab Clin Med 1991; 118: 576-584.
Библиографическая ссылка Bone RC, Balk RA, Cerra FB, Dellinger RPDefinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest1992; 101: 1644-1655.
Библиографическая ссылка Strieter RM , Lynch III JP, Basha MA, Standiford TJ, Kasahara K., Kunkel SL Host responses in mediating sepsis and adult respiratory distress syndrome. Semin Resp Infect 1990; 5: 233-247.
Библиографическая ссылка Görgen I., Hartung T., Leist M. et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J Immunol 1992; 149: 918-924.
Библиографическая ссылка Hartung T., Wendel A.Endotoxin-inducible cytotoxicity in liver cell cultures. Biochem Pharmacol1991; 42: 1129-1135.
Библиографическая ссылка Espevik T., Nissen-Meyer J.A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth1986; 95: 99-105.
Библиографическая ссылка Wilson Bmg, Severn A., Rapson NT, Chana J., Hopkins P.A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide. J Immunol Meth1991; 139: 233-240.
Библиографическая ссылка Hartung T., Wendel A.Endotoxin-inducible cytotoxicity in liver cell cultures. II: Demonstration of endotoxin-tolerance. Biochem Pharmacol1992; 43: 191-196.
Библиографическая ссылка Hartung T., Krieger G., Volk H-D., Wendel A.Reduced proinflammatory cytokines and increased antagonists in LPS-stimulated blood from G-CSF treated volunteers. Intens Care Med1994; 20: S142.
Библиографическая ссылка Hartung T., Döcke W-D., Gantner F. et al. Effect of G-CSF treatment on ex vivo blood cytokine response in human volunteers. Blood 1995, In press.
Библиографическая ссылка Tiegs G., Barsig J., Matiba B., Uhlig S., Wendel A.Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest1994; 93: 2616.

Скрыть метаданые